de Boer Daniel Anton
Executive buyerDirector, Chief Executive Officer · ProQR Therapeutics N.V.
Every open-market stock purchase de Boer Daniel Anton has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- PRQRProQR Therapeutics N.V.
2 purchases totalling $499.5K at an average of $1.67 per share. See all insider buying in PRQR →
Avg price paid$1.67Latest price—Market capUnknown
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
Follow new qualifying clusters involving de Boer Daniel Anton or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from de Boer Daniel Anton's Form 4 filings on SEC EDGAR (CIK 2117546) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.